Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > An additional 1,378,843 shares of common stock may be ....

<< Previous

Bullboard Posts

Next >>

Post by TreborTheGreaton Oct 16, 2023 10:33am

123 Views

Post# 35685261

An additional 1,378,843 shares of common stock may be ....

An additional 1,378,843 shares of common stock may be issuable to MediPharm to the extent the VWAP of Tilray’s common stock for the five trading days ending on October 9, 2023 declines below $2.3958."

That reads to most people up to 1.378 based on possible trading losses.

Trading losses MEDIF did not want to have should they try to move such a large amount of shares.

Another thing is don't presume they did sell. You don't know. Maybe they did or did not.